Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Switzerland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20072
20081
20111
20163
20201
20211
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
European Organisation for Research and Treatment of Cancer - EORTC2
Oncology Institute of Southern Switzerland2
Swiss Cancer Institute2
AstraZeneca1
Cantonal Hospital of St. Gallen1
EBMT Solid Tumors Working Party1
ImmunoGen, Inc.1
Incyte Corporation1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial18
Ovarian Neoplasms7
Neoplasms5
Breast Neoplasms4
Carcinoma, Renal Cell4
Fallopian Tube Neoplasms4
Stomach Neoplasms4
Endometrial Neoplasms3
Esophageal Neoplasms3
Pancreatic Neoplasms3

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.